PYLARIFY
Progenics Pharmaceuticals, Inc.
Mark For: PYLARIFY® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88647018 |
| Registration Number | 1529733 |
| Mark Literal Elements | PYLARIFY |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | DIVISIONAL UNIT 2020-07-01 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Phi Lan M. Tinsley |
| Attorney Docket Number | MIN.629.US |
Timeline
| 2019-10-08 | Application Filed |
| 2019-10-16 | Location: NEW APPLICATION PROCESSING |
| 2019-10-16 | Status: Live/Pending |
| 2019-10-18 | Transaction Date |
| 2020-02-25 | Published |
| 2020-07-01 | Location: DIVISIONAL UNIT |
| 2021-04-09 | Status: A second request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Progenics Pharmaceuticals, Inc. |
| Address | One World Trade Center 47th Floor Suite J New York, NEW YORK UNITED STATES 10007 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2019-10-08 |
 TEAS RF New Application | MULTI | 2019-10-08 |
| Examiners Amendment | XML | 2020-01-17 |
| XSearch Search Summary | XML | 2020-01-17 |
| Amendment and Mail Process Complete | MULTI | 2020-01-18 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-01-18 |
| Notice of Publication | XML | 2020-02-05 |
| Notification Of Notice of Publication | XML | 2020-02-05 |
| OG Publication Confirmation | XML | 2020-02-25 |
| Notice of Allowance | XML | 2020-04-21 |
| Extension of Time to File SOU | MULTI | 2020-06-17 |
| Request to Divide | MULTI | 2020-06-17 |
| Offc Action Outgoing | XML | 2020-07-01 |
| ITU Extension Approval | XML | 2020-07-02 |
| ITU Unit Action | MULTI | 2020-07-02 |
| Notice of Allowance | XML | 2020-07-02 |
| Change Address or Representation Form | MULTI | 2020-12-03 |
| Extension of Time to File SOU | XML | 2021-04-09 |
| ITU Extension Approval | XML | 2021-04-13 |
| ITU Unit Action | MULTI | 2021-04-13 |
Attorney of Record
Good, Services, and Codes
IC 042. US 100 101. G & S: Scientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; Providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer
IC 044. US 100 101. G & S: Providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; Web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis, prevention, treatment and monitoring of cancer |
| GS0441 | Providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; Web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-04-13 | |
| TEAS EXTENSION RECEIVED | 2021-04-09 | |
| EXTENSION 2 GRANTED | 2021-04-09 | 98765 |
| EXTENSION 2 FILED | 2021-04-09 | 98765 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-12-03 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-12-03 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-12-03 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-12-03 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-12-03 | 88888 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-07-02 | |
| CORRECTED NOA E-MAILED | 2020-07-02 | |
| EXTENSION 1 GRANTED | 2020-07-01 | 74055 |
| DIVISIONAL PROCESSING COMPLETE | 2020-07-01 | |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-07-01 | 74055 |
| TEAS REQUEST TO DIVIDE RECEIVED | 2020-06-17 | |
| TEAS EXTENSION RECEIVED | 2020-06-17 | |
| EXTENSION 1 FILED | 2020-06-17 | 74055 |
| DIVISIONAL REQUEST RECEIVED | 2020-06-17 | |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-04-21 | |
| PUBLISHED FOR OPPOSITION | 2020-02-25 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-02-25 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-02-05 | |
| ASSIGNED TO LIE | 2020-01-21 | 70884 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-01-17 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2020-01-17 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2020-01-17 | 76134 |
| EXAMINER'S AMENDMENT ENTERED | 2020-01-17 | 88888 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-01-17 | |
| ASSIGNED TO EXAMINER | 2020-01-13 | 76134 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-10-15 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-10-11 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PYLARIFY 88978293 not registered Live/Pending |
Progenics Pharmaceuticals, Inc. 2019-10-08 |
 PYLARIFY 88647018 not registered Live/Pending |
Progenics Pharmaceuticals, Inc. 2019-10-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 